Psychiatric diseases predated the occurrence of Parkinson disease: A retrospective cohort study

Annals of Epidemiology

Volumn 24, Issue 3, 2014, Pages 206-213

  Lin, Hsiu Li ^a   Lin, Herng Ching ^b   Chen, Yi Hua ^b  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anxiety; Bipolar disorder; Depression; Parkinson disease; Schizophrenia

Indexed keywords

ANXIETY; BIPOLAR DISORDER; DEPRESSION; PARKINSON DISEASE; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGE FACTORS; ANXIETY DISORDERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; SCHIZOPHRENIA; SOCIOECONOMIC FACTORS; TAIWAN; YOUNG ADULT;

EID: 84893918893     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.12.010     Document Type: Article

References (42)

1. Tanner C.M., Goldman S.M. Epidemiology of Parkinson's disease. Neurol Clin 1996, 14(2):317-335.
2. Mayeux R., Marder K., Cote L.J., Denaro J., Hemenegildo N., Mejia H., et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995, 142(8):820-827.
3. Zhang Z.X., Roman G.C. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993, 12(4):195-208.
4. Semchuk K.M., Love E.J., Lee R.G. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993, 43(6):1173-1180.
5. Seidler A., Hellenbrand W., Robra B.P., Vieregge P., Nischan P., Joerg J., et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 1996, 46(5):1275-1284.
6. Bower J.H., Maraganore D.M., Peterson B.J., McDonnell S.K., Ahlskog J.E., Rocca W.A. Head trauma preceding PD: a case-control study. Neurology 2003, 60(10):1610-1615.
7. Rajput A.H., Offord K.P., Beard C.M., Kurland L.T. Acase-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology 1987, 37(2):226-232.
8. Hubble J.P., Cao T., Hassanein R.E., Neuberger J.S., Koller W.C. Risk factors for Parkinson's disease. Neurology 1993, 43(9):1693-1697.
9. Weisskopf M.G., Chen H., Schwarzschild M.A., Kawachi I., Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003, 18(6):646-651.
10. Bower J.H., Grossardt B.R., Maraganore D.M., Ahlskog J.E., Colligan R.C., Geda Y.E., et al. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010, 25(13):2105-2113.
11. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000, 15(4):669-677.
12. Leentjens A.F., Van den Akker M., Metsemakers J.F., Lousberg R., Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 2003, 18(4):414-418.
13. Nilsson F.M., Kessing L.V., Sorensen T.M., Andersen P.K., Bolwig T.G. Major depressive disorder in Parkinson's disease: a register-based study. Acta Psychiatr Scand 2002, 106(3):202-211.
14. Schuurman A.G., van den Akker M., Ensinck K.T., Metsemakers J.F., Knottnerus J.A., Leentjens A.F., et al. Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 2002, 58(10):1501-1504.
15. Behari M., Srivastava A.K., Das R.R., Pandey R.M. Risk factors of Parkinson's disease in Indian patients. JNeurol Sci 2001, 190(1-2):49-55.
16. Sanyal J., Chakraborty D.P., Sarkar B., Banerjee T.K., Mukherjee S.C., Ray B.C., et al. Environmental and familial risk factors of Parkinsons disease: case-control study. Can J Neurol Sci 2010, 37(5):637-642.
17. Ishihara L., Brayne C. Asystematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 2006, 113(4):211-220.
18. Gonera E.G., van't Hof M., Berger H.J., van Weel C., Horstink M.W. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997, 12(6):871-876.
19. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
20. 18F] dopa PET. JNeurol Neurosurg Psychiatry 1998, 64:314-319.
21. Nilsson F.M., Kessing L.V., Bolwig T.G. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 2001, 104(5):380-386.
22. Taylor C.A., Saint-Hilaire M.H., Cupples L.A., Thomas C.A., Burchard A.E., Feldman R.G., et al. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet 1999, 88(6):742-749.
23. McCann S.J., LeCouteur D.G., Green A.C., Brayne C., Johnson A.G., Chan D., et al. The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology 1998, 17(6):310-317.
24. Todes C.J., Lees A.J. The pre-morbid personality of patients with Parkinson's disease. JNeurol Neurosurg Psychiatry 1985, 48(2):97-100.
25. Videbech P. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand 1997, 96(3):157-168.
26. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 2000, 101(1):11-20.
27. Drevets W.C. Neuroimaging studies of mood disorders. Biol Psychiatry 2000, 48(8):813-829.
28. Allain H., Schuck S., Mauduit N. Depression in Parkinson's disease. Bmj 2000, 320(7245):1287-1288.
29. Cummings J.L. Depression and Parkinson's disease: a review. Am J Psychiatry 1992, 149(4):443-454.
30. Birtwistle J., Baldwin D. Role of dopamine in schizophrenia and Parkinson's disease. Br J Nurs 1998, 7(14):832-834. 6, 8-41.
31. Winograd-Gurvich C., Fitzgerald P.B., Georgiou-Karistianis N., Bradshaw J.L., White O.B. Negative symptoms: a review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull 2006, 70(4-6):312-321.
32. von Campenhausen S., Bornschein B., Wick R., Bötzel K., Sampaio C., Poewe W., et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005, 15(4):473-490.
33. Lai S.W., Liao K.F., Lin C.L., Sung F.C. Association between head injury and Parkinson's disease: an observation in Taiwan. Geriatr Gerontol Int 2013, 13(2):513-514.
34. Sheu J.J., Wang K.H., Lin H.C., Huang C.C. Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. JAm Acad Dermatol 2013, 68(6):992-999.
35. Gibb W.R.G., Lees A.J. Acomparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988, 38:1402-1406.
36. Tsai C.H., Lo S.K., See L.C., Chen H.Z., Chen R.S., Weng Y.H., et al. Environmental risk factors of young onset Parkinson's disease: a case-control study. Clinical neurology and neurosurgery 2002, 104(4):328-333.
37. Stern M., Dulaney E., Gruber S.B., Golbe L., Bergen M., Hurtig H., et al. The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients. Archives of neurology 1991, 48(9):903-907.
38. Murman D.L. Early treatment of Parkinson's disease: opportunities for managed care. Am J Manag Care 2012, 18(7 Suppl):S183-S188.
39. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55(3):181-184.
40. Osborn D.P., Wright C.A., Levy G., King M.B., Deo R., Nazareth I. Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC psychiatry 2008, 8:84.
41. Vestergaard P., Schou M. Lithium treatment in Aarhus. 1. Prevalence. Pharmacopsychiatry 1989, 22(3):99-100.
42. Fang F., Xu Q., Park Y., Huang X., Hollenbeck A., Blair A., et al. Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study. Mov Disord 2010, 25(9):1157-1162.